1. Cellular Assays with a Molecular Endpoint Measured by SAMDI Mass Spectrometry
- Author
-
Maria D. Cebezas, Eric J. Berns, and Milan Mrksich
- Subjects
0301 basic medicine ,chemistry.chemical_classification ,Chromatography ,Chemistry ,Nanotechnology ,General Chemistry ,Mass spectrometry ,01 natural sciences ,Article ,Mass Spectrometry ,Enzymes ,High-Throughput Screening Assays ,Substrate Specificity ,0104 chemical sciences ,Biomaterials ,010404 medicinal & biomolecular chemistry ,03 medical and health sciences ,030104 developmental biology ,Enzyme ,Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ,High-content screening ,Substrate specificity ,General Materials Science ,Biotechnology - Abstract
Cell-based, high-throughput screening (HTS) assays are increasingly important tools used in drug discovery, but frequently rely on readouts of gene expression or phenotypic changes and require development of specialized, labeled reporters. Here a cell-based, label-free assay compatible with HTS is introduced that can report quantitatively on enzyme activities by measuring mass changes of substrates with matrix-assisted laser desorption/ionization mass spectrometry. The assay uses self-assembled monolayers to culture cells on arrays presenting substrates, which serve as reporters for a desired enzyme activity. Each spot of cells is treated with a compound, cultured and lysed, enabling endogenous enzymes to act on the immobilized peptide substrate. It is demonstrated that the assay can measure protein tyrosine phosphatase (PTP) activity from as few as five cells and a screen is described that identifies a compound that reduces PTP activity in cell lysates. This approach offers a valuable addition to the methods available for cell-based screening.
- Published
- 2016
- Full Text
- View/download PDF